Purpose. There has been recent interest in the use of brachytherapy for the possible prevention of restenosis after angioplasty. However, this field is unfamiliar to most interventional cardiologists. This article is meant to serve as an introduction to the principles of brachytherapy especially as ...
The CHAMPIONS program was founded in 2022 by vascular surgeon Dr. Leigh Ann O’Banion and cardiologist Dr. Teresa Daniele of University of California San Francisco (UCSF) Fresno in the San Joaquin Valley (SJV) of California through partnership and financial support from Abbott. The SJV is a va...
We offer many vein procedures and are happy to help you get back to the healthiest legs of your life. Contact us here!
To ensure unbiased patient selection, an interventional cardiologist and cardiac surgeon were paired at each site and asked to reach consensus about the appropriateness of enrolling each patient. The application of such a team approach was novel and constructive 6, 7. Shortly after publication of ...
Without question, interventional cardiologists and neuroradiologists are technically superior in performing many percutaneous arterial interventions; however, as surgeons, we know that treating carotid artery occlusive disease is more than just doing CAS or CEA. The treatment of this disease process ...
Surgery can be performed with cardiopulmonary bypass or as an off-pump procedure according to the experience of the surgeon. The following surgical procedures should be applied depending on the allocation to SIMA or BIMA:- SIMA –standard operation using SIMA to LAD plus supplemental vein or radial...
Dietzek is a Board Certified General and Vascular Surgeon practicing since 1989. He was a faculty member and the Chief of Vascular Surgery at Rowan School of Osteopathic Medicine for fifteen years. In August 2005, he founded the Vein & Vascular Institute where he remains as the Medical Director...
Intravascular brachytherapy is currently considered to be experimental. Those wishing to start a new intravascular brachytherapy program should comply with the required federal and state regulatory guidelines issued by the Nuclear Regulatory Commission, Food and Drug Administration, and their individual ...
Levin DC, Rao VM, Parker L et al (2005) The changing roles of radiologists, cardiologists, and vascular surgeons in percutaneous peripheral arterial interventions during a recent five-year interval. J Am Coll Radiol 2(1):39-42Levin DC , Rao VM , Parker L , Bonn J , Maitino AJ , ...
2 The ACAS recommended CEA for patients aged <80 years as long as the expected combined stroke and mortality rate for the individual surgeon was not >3%. The conclusions from the ACAS were supported by a subsequent larger RCT that had randomized 3120 patients to immediate CEA vs medical ...